Abstract
Cerebrovascular reactivity (CVR), defined as the ability of the cerebral vasculature to dilate or constrict in response to a vasoactive stimulus, is an important indicator of the brain’s vascular health.1 Impaired CVR is present in numerous disease states, including cerebrovascular disease,2 – 8 stroke,9 – 12 cardiovascular disease,13,14 cardiac arrest,15 traumatic brain injury,16 – 19 diabetes,20 and sleep apnea.21 Moreover, several studies have suggested that impaired CVR may serve as a prognostic biomarker of functional outcome.22 – 25 Despite mounting evidence for the relevance of CVR as a potential disease biomarker, mechanisms of cerebrovascular dysregulation are poorly understood, and effective treatment strategies for impaired CVR are lacking.
Funding Information
  • National Institutes of Health (R21 NS104801)
  • National Institutes of Health (R01 NS115994)

This publication has 68 references indexed in Scilit: